Free Trial

MyHealthChecked (MHC) Competitors

MyHealthChecked logo
GBX 12.50 +0.75 (+6.38%)
As of 11:47 AM Eastern

MHC vs. POLX, IHC, AVO, RUA, SUN, BELL, DEMG, NIOX, SN, and MXCT

Should you be buying MyHealthChecked stock or one of its competitors? The main competitors of MyHealthChecked include Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), Belluscura (BELL), Deltex Medical Group (DEMG), NIOX Group (NIOX), Smith & Nephew (SN), and MaxCyte (MXCT). These companies are all part of the "medical devices" industry.

MyHealthChecked vs.

Polarean Imaging (LON:POLX) and MyHealthChecked (LON:MHC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations, risk and community ranking.

12.1% of Polarean Imaging shares are held by institutional investors. Comparatively, 3.1% of MyHealthChecked shares are held by institutional investors. 39.3% of Polarean Imaging shares are held by company insiders. Comparatively, 53.6% of MyHealthChecked shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

MyHealthChecked has a net margin of -11.06% compared to Polarean Imaging's net margin of -1,333.97%. MyHealthChecked's return on equity of -12.80% beat Polarean Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Polarean Imaging-1,333.97% -86.11% -32.28%
MyHealthChecked -11.06%-12.80%-8.18%

In the previous week, Polarean Imaging had 1 more articles in the media than MyHealthChecked. MarketBeat recorded 1 mentions for Polarean Imaging and 0 mentions for MyHealthChecked. Polarean Imaging's average media sentiment score of 0.68 beat MyHealthChecked's score of 0.00 indicating that Polarean Imaging is being referred to more favorably in the media.

Company Overall Sentiment
Polarean Imaging Positive
MyHealthChecked Neutral

MyHealthChecked has higher revenue and earnings than Polarean Imaging. MyHealthChecked is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Polarean Imaging£5.21M3.31-£69.44M-£3.89-0.30
MyHealthChecked£9.43M0.69-£1.04M-£2.00-6.23

Polarean Imaging received 23 more outperform votes than MyHealthChecked when rated by MarketBeat users.

CompanyUnderperformOutperform
Polarean ImagingOutperform Votes
23
67.65%
Underperform Votes
11
32.35%
MyHealthCheckedN/AN/A

Polarean Imaging has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500. Comparatively, MyHealthChecked has a beta of 1.37, suggesting that its share price is 37% more volatile than the S&P 500.

Summary

MyHealthChecked beats Polarean Imaging on 8 of the 14 factors compared between the two stocks.

Get MyHealthChecked News Delivered to You Automatically

Sign up to receive the latest news and ratings for MHC and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MHC vs. The Competition

MetricMyHealthCheckedMedical Devices IndustryMedical SectorLON Exchange
Market Cap£6.50M£3.30B£5.33B£2.66B
Dividend YieldN/A2.44%5.21%5.05%
P/E Ratio-6.2368.2226.85129.21
Price / Sales0.69105.70388.74221,406.02
Price / Cash1.7815.9938.2528.02
Price / Book0.863.596.763.79
Net Income-£1.04M£126.02M£3.23B£5.88B
7 Day Performance3.09%4.40%1.71%0.63%
1 Month Performance-3.85%7.62%11.16%22.11%
1 Year Performance11.11%-3.76%17.17%120.87%

MyHealthChecked Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MHC
MyHealthChecked
N/AGBX 12.50
+6.4%
N/A+28.7%£6.50M£9.43M-6.2316Gap Down
POLX
Polarean Imaging
N/AGBX 1.21
+0.8%
N/A-68.3%£17.76M£5.21M-0.3128Gap Down
High Trading Volume
IHC
Inspiration Healthcare Group
N/AGBX 17.95
-0.3%
N/A+13.8%£15.55M£42.87M-1.23224Gap Down
High Trading Volume
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
RUA
RUA Life Sciences
N/AGBX 11.53
-3.9%
N/A+1.7%£7.15M£4.05M-2.6948Positive News
SUN
Surgical Innovations Group
N/AGBX 0.65
flat
N/A+40.0%£6.06M£12.54M-21.1180Gap Up
BELL
Belluscura
N/AGBX 1
-12.3%
N/A-94.2%£2.52M£2.87M-0.1124High Trading Volume
DEMG
Deltex Medical Group
N/AN/AN/AN/A£187,000.00£1.76M-0.1537Gap Up
High Trading Volume
NIOX
NIOX Group
1.9447 of 5 stars
GBX 67.20
-4.0%
GBX 90
+33.9%
-10.3%£27.60B£3.53B2,773.2392News Coverage
Insider Trade
High Trading Volume
SN
Smith & Nephew
3.4243 of 5 stars
GBX 1,056.50
-0.9%
GBX 7,840
+642.1%
+7.9%£11.58B£7.08B38.0418,452High Trading Volume
MXCT
MaxCyte
N/AGBX 164
-1.2%
N/A-55.4%£216.49M£57.52M-6.0180

Related Companies and Tools


This page (LON:MHC) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners